학술논문

Mitigating hERG Inhibition: Design of Orally Bioavailable CCR5 Antagonists as Potent Inhibitors of R5 HIV-1 Replication
Document Type
Journal
Source
ACS MEDICINAL CHEMISTRY LETTERS; MAR 2012, 3 3, p216-p221, 6p.
Subject
Language
English
ISSN
19485875